Max Fürst
banner
maxfus.bsky.social
Max Fürst
@maxfus.bsky.social
Asst. Prof. Uni Groningen 🇳🇱
Comp & Exp Biochemist, Protein Engineer, 'Would-be designer' (F. Arnold) | SynBio | HT Screens & Selections | Nucleic Acid Enzymes | Biocatalysis | Rstats & Datavis
https://www.fuerstlab.com
https://orcid.org/0000-0001-7720-9
with MD, with AI MDemulators, with AF hacks, ...
January 13, 2026 at 6:23 AM
Thanks for sharing. Not surprised but good to see data also for antibodies that squares really well with our analysis on protein design more generally
bsky.app/profile/maxf...
New preprint🚨
Imagine (re)designing a protein via inverse folding. AF2 predicts the designed sequence to a structure with pLDDT 94 & you get 1.8 Å RMSD to the input. Perfect design?
What if I told u that the structure has 4 solvent-exposed Trp and 3 Pro where a Gly should be?

Why to be wary🧵👇
January 10, 2026 at 7:34 PM
Exactly
January 9, 2026 at 7:58 PM
Yea this is not the same of course, but it just popped up in my feed and was close enough in topic ;)
Still, there might be something there. Sample unbiased random flex and score with IF?
January 8, 2026 at 7:59 PM
Inverse folding much more promising
bsky.app/profile/alic...
Video introduction to our new “Conformational Biasing” method for computational design of mutations that bias proteins towards desired conformational states

CB part starts at 14:55

Thanks to Peter Cavanagh and Andrew Xue – amazing graduate students who co-led this work
Alice Ting Rosettacon keynote 2025
YouTube video by Alice Ting
www.youtube.com
January 8, 2026 at 7:53 PM
Personally skeptical of a paper making broad claims about such methods capturing mutation effects when their data is a single mutation in a single enzyme where effect is extensively studied & captured in many training data structures. AI
structure/dynamics prediction tools are very poor VAEs imo
January 8, 2026 at 6:34 PM
Fantastic! Had 3 Qs after thread & think I understood from paper myself
1 were the 500 ligands v similar? - No, quite diverse
2 did they do "fair" real-life docking when comparing - i think so
3 is one limitation that all results are for one receptor & might not generalize? - probably
Would u agree?
December 30, 2025 at 10:28 AM
Nice first step indeed. But were the ribosomal proteins ever the bottleneck? I'd expect rRNA and tRNAs first and can't rebuild without all the RNA modification enzymes. But probably IVTT anyway usually stops due to ATP depletion, right?
December 18, 2025 at 2:09 PM
Precisely. And that's what we want to encourage: implement custom scoring suitable for your goal to try to mitigate the shortcoming of refolding metrics. Or, for novices who may not be able to do much in this regard, at least be skeptical of these metrics
December 18, 2025 at 2:03 PM
Well many sequences require chaperones or only get structured in complex with something, but this is not so easy to compile data. Synthetic nonsense would probably be easiest but whether this can be well implemented in training without compromising positive performance is a question.
December 18, 2025 at 12:17 PM
Ohh nice, hadn't seen that then! Might have reconsidered terminology in the title if I had.. 😅
December 18, 2025 at 11:24 AM
I'd say so - AF2 just hasn't ever seen any negative data. We discuss this a bit in the paper although refrain from speculating to widely.
December 18, 2025 at 9:59 AM
20/19
Or, you know, if bioRxiv is down / extremely slow again, download the pdf here:
www.fuerstlab.com/uploads/2025...
www.fuerstlab.com
December 18, 2025 at 9:57 AM
MSA struc as temp to ss I'd expect similar to MSA but maybe worth a shot. Energy based I guess will not fold nonsense, thus hard to implement in our tests except maybe in very low mutation regime; could test that in pMPNN background. Will think, thanks!
December 16, 2025 at 7:53 PM
Thanks to Seva and Kerlen for their tireless effort to get the data as watertight as possible.
Here is the preprint link again:
www.biorxiv.org/content/10.6...
19/19
Limitations of the refolding pipeline for de novo protein design
With the emergence of powerful deep learning-based tools, computational protein design has become a widely accessible technique. Nowadays, it is possible to perform both sequence and structure design ...
www.biorxiv.org
December 16, 2025 at 3:32 PM